Switch to:
Also traded in: Germany, Switzerland, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.06
FSNUY's Cash to Debt is ranked lower than
82% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 0.31 vs. FSNUY: 0.06 )
Ranked among companies with meaningful Cash to Debt only.
FSNUY' s Cash to Debt Range Over the Past 10 Years
Min: 0.05  Med: 0.08 Max: N/A
Current: 0.06
Equity to Asset 0.25
FSNUY's Equity to Asset is ranked lower than
78% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. FSNUY: 0.25 )
Ranked among companies with meaningful Equity to Asset only.
FSNUY' s Equity to Asset Range Over the Past 10 Years
Min: 0.2  Med: 0.24 Max: 0.26
Current: 0.25
0.2
0.26
F-Score: 6
Z-Score: 1.60
M-Score: -2.54
WACC vs ROIC
5.52%
10.84%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 13.66
FSNUY's Operating margin (%) is ranked higher than
74% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 7.46 vs. FSNUY: 13.66 )
Ranked among companies with meaningful Operating margin (%) only.
FSNUY' s Operating margin (%) Range Over the Past 10 Years
Min: 11.97  Med: 14.34 Max: 15.67
Current: 13.66
11.97
15.67
Net-margin (%) 4.67
FSNUY's Net-margin (%) is ranked higher than
53% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 4.28 vs. FSNUY: 4.67 )
Ranked among companies with meaningful Net-margin (%) only.
FSNUY' s Net-margin (%) Range Over the Past 10 Years
Min: 2.8  Med: 4.70 Max: 7.54
Current: 4.67
2.8
7.54
ROE (%) 12.73
FSNUY's ROE (%) is ranked higher than
63% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 9.24 vs. FSNUY: 12.73 )
Ranked among companies with meaningful ROE (%) only.
FSNUY' s ROE (%) Range Over the Past 10 Years
Min: 7.27  Med: 12.38 Max: 13.61
Current: 12.73
7.27
13.61
ROA (%) 3.06
FSNUY's ROA (%) is ranked lower than
54% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 3.51 vs. FSNUY: 3.06 )
Ranked among companies with meaningful ROA (%) only.
FSNUY' s ROA (%) Range Over the Past 10 Years
Min: 2.23  Med: 3.07 Max: 5.42
Current: 3.06
2.23
5.42
ROC (Joel Greenblatt) (%) 36.03
FSNUY's ROC (Joel Greenblatt) (%) is ranked higher than
67% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 20.18 vs. FSNUY: 36.03 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
FSNUY' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 32.88  Med: 40.03 Max: 43.25
Current: 36.03
32.88
43.25
Revenue Growth (3Y)(%) 8.70
FSNUY's Revenue Growth (3Y)(%) is ranked higher than
54% of the 160 Companies
in the Global Medical Care industry.

( Industry Median: 8.20 vs. FSNUY: 8.70 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
FSNUY' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -44.6  Med: 7.75 Max: 10.5
Current: 8.7
-44.6
10.5
EBITDA Growth (3Y)(%) 5.80
FSNUY's EBITDA Growth (3Y)(%) is ranked lower than
57% of the 128 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. FSNUY: 5.80 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
FSNUY' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -48.9  Med: 7.65 Max: 24.5
Current: 5.8
-48.9
24.5
EPS Growth (3Y)(%) 11.90
FSNUY's EPS Growth (3Y)(%) is ranked higher than
54% of the 118 Companies
in the Global Medical Care industry.

( Industry Median: 9.00 vs. FSNUY: 11.90 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
FSNUY' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -35.6  Med: 12.40 Max: 35.2
Current: 11.9
-35.6
35.2
» FSNUY's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with FSNUY

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 24.58
FSNUY's P/E(ttm) is ranked higher than
55% of the 265 Companies
in the Global Medical Care industry.

( Industry Median: 27.90 vs. FSNUY: 24.58 )
Ranked among companies with meaningful P/E(ttm) only.
FSNUY' s P/E(ttm) Range Over the Past 10 Years
Min: 14.27  Med: 19.49 Max: 34.54
Current: 24.58
14.27
34.54
Forward P/E 16.16
FSNUY's Forward P/E is ranked higher than
54% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 16.75 vs. FSNUY: 16.16 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 24.58
FSNUY's PE(NRI) is ranked higher than
51% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 24.85 vs. FSNUY: 24.58 )
Ranked among companies with meaningful PE(NRI) only.
FSNUY' s PE(NRI) Range Over the Past 10 Years
Min: 10.36  Med: 18.07 Max: 30.41
Current: 24.58
10.36
30.41
P/B 2.97
FSNUY's P/B is ranked lower than
59% of the 303 Companies
in the Global Medical Care industry.

( Industry Median: 2.53 vs. FSNUY: 2.97 )
Ranked among companies with meaningful P/B only.
FSNUY' s P/B Range Over the Past 10 Years
Min: 0.73  Med: 2.20 Max: 5.45
Current: 2.97
0.73
5.45
P/S 1.11
FSNUY's P/S is ranked higher than
56% of the 301 Companies
in the Global Medical Care industry.

( Industry Median: 1.26 vs. FSNUY: 1.11 )
Ranked among companies with meaningful P/S only.
FSNUY' s P/S Range Over the Past 10 Years
Min: 0.38  Med: 0.58 Max: 1.41
Current: 1.11
0.38
1.41
PFCF 19.10
FSNUY's PFCF is ranked higher than
55% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 20.37 vs. FSNUY: 19.10 )
Ranked among companies with meaningful PFCF only.
FSNUY' s PFCF Range Over the Past 10 Years
Min: 3.67  Med: 9.92 Max: 83.14
Current: 19.1
3.67
83.14
POCF 10.10
FSNUY's POCF is ranked higher than
74% of the 275 Companies
in the Global Medical Care industry.

( Industry Median: 14.09 vs. FSNUY: 10.10 )
Ranked among companies with meaningful POCF only.
FSNUY' s POCF Range Over the Past 10 Years
Min: 3.67  Med: 5.46 Max: 15.52
Current: 10.1
3.67
15.52
EV-to-EBIT 13.47
FSNUY's EV-to-EBIT is ranked higher than
68% of the 290 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. FSNUY: 13.47 )
Ranked among companies with meaningful EV-to-EBIT only.
FSNUY' s EV-to-EBIT Range Over the Past 10 Years
Min: 3.6  Med: 10.40 Max: 15.7
Current: 13.47
3.6
15.7
EV-to-EBITDA 10.48
FSNUY's EV-to-EBITDA is ranked higher than
65% of the 303 Companies
in the Global Medical Care industry.

( Industry Median: 12.05 vs. FSNUY: 10.48 )
Ranked among companies with meaningful EV-to-EBITDA only.
FSNUY' s EV-to-EBITDA Range Over the Past 10 Years
Min: 2.8  Med: 8.20 Max: 12.2
Current: 10.48
2.8
12.2
PEG 3.80
FSNUY's PEG is ranked lower than
64% of the 76 Companies
in the Global Medical Care industry.

( Industry Median: 2.75 vs. FSNUY: 3.80 )
Ranked among companies with meaningful PEG only.
FSNUY' s PEG Range Over the Past 10 Years
Min: 0.52  Med: 1.37 Max: 23.39
Current: 3.8
0.52
23.39
Current Ratio 1.49
FSNUY's Current Ratio is ranked higher than
61% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 1.33 vs. FSNUY: 1.49 )
Ranked among companies with meaningful Current Ratio only.
FSNUY' s Current Ratio Range Over the Past 10 Years
Min: 0.98  Med: 1.37 Max: 1.57
Current: 1.49
0.98
1.57
Quick Ratio 1.10
FSNUY's Quick Ratio is ranked lower than
56% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 1.22 vs. FSNUY: 1.10 )
Ranked among companies with meaningful Quick Ratio only.
FSNUY' s Quick Ratio Range Over the Past 10 Years
Min: 0.75  Med: 1.03 Max: 1.21
Current: 1.1
0.75
1.21
Days Inventory 49.55
FSNUY's Days Inventory is ranked lower than
79% of the 157 Companies
in the Global Medical Care industry.

( Industry Median: 16.67 vs. FSNUY: 49.55 )
Ranked among companies with meaningful Days Inventory only.
FSNUY' s Days Inventory Range Over the Past 10 Years
Min: 36.94  Med: 45.86 Max: 51.96
Current: 49.55
36.94
51.96
Days Sales Outstanding 63.94
FSNUY's Days Sales Outstanding is ranked lower than
74% of the 187 Companies
in the Global Medical Care industry.

( Industry Median: 45.70 vs. FSNUY: 63.94 )
Ranked among companies with meaningful Days Sales Outstanding only.
FSNUY' s Days Sales Outstanding Range Over the Past 10 Years
Min: 0.65  Med: 66.22 Max: 72.15
Current: 63.94
0.65
72.15
Days Payable 20.04
FSNUY's Days Payable is ranked lower than
74% of the 144 Companies
in the Global Medical Care industry.

( Industry Median: 42.47 vs. FSNUY: 20.04 )
Ranked among companies with meaningful Days Payable only.
FSNUY' s Days Payable Range Over the Past 10 Years
Min: 0.26  Med: 23.36 Max: 26.98
Current: 20.04
0.26
26.98

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.80
FSNUY's Dividend Yield is ranked lower than
85% of the 249 Companies
in the Global Medical Care industry.

( Industry Median: 2.08 vs. FSNUY: 0.80 )
Ranked among companies with meaningful Dividend Yield only.
FSNUY' s Dividend Yield Range Over the Past 10 Years
Min: 0.63  Med: 1.08 Max: 2.23
Current: 0.8
0.63
2.23
Dividend Payout 0.19
FSNUY's Dividend Payout is ranked higher than
86% of the 146 Companies
in the Global Medical Care industry.

( Industry Median: 0.71 vs. FSNUY: 0.19 )
Ranked among companies with meaningful Dividend Payout only.
FSNUY' s Dividend Payout Range Over the Past 10 Years
Min: 0.6  Med: 0.80 Max: 1.1
Current: 0.19
0.6
1.1
Dividend Growth (3y) 13.30
FSNUY's Dividend Growth (3y) is ranked higher than
55% of the 64 Companies
in the Global Medical Care industry.

( Industry Median: 11.00 vs. FSNUY: 13.30 )
Ranked among companies with meaningful Dividend Growth (3y) only.
FSNUY' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 25.9
Current: 13.3
0
25.9
Forward Dividend Yield 0.80
FSNUY's Forward Dividend Yield is ranked lower than
78% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 2.09 vs. FSNUY: 0.80 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 1.65
FSNUY's Yield on cost (5-Year) is ranked lower than
67% of the 257 Companies
in the Global Medical Care industry.

( Industry Median: 2.53 vs. FSNUY: 1.65 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
FSNUY' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 1.3  Med: 2.23 Max: 4.6
Current: 1.65
1.3
4.6
3-Year Average Share Buyback Ratio -3.40
FSNUY's 3-Year Average Share Buyback Ratio is ranked lower than
58% of the 120 Companies
in the Global Medical Care industry.

( Industry Median: -2.20 vs. FSNUY: -3.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
FSNUY' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -96.4  Med: -3.40 Max: -1.1
Current: -3.4
-96.4
-1.1

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.13
FSNUY's Price/Projected FCF is ranked higher than
66% of the 171 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. FSNUY: 1.13 )
Ranked among companies with meaningful Price/Projected FCF only.
FSNUY' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.38  Med: 1.20 Max: 1.76
Current: 1.13
0.38
1.76
Price/Median PS Value 1.37
FSNUY's Price/Median PS Value is ranked lower than
66% of the 300 Companies
in the Global Medical Care industry.

( Industry Median: 1.05 vs. FSNUY: 1.37 )
Ranked among companies with meaningful Price/Median PS Value only.
FSNUY' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.68  Med: 0.98 Max: 2.13
Current: 1.37
0.68
2.13
Price/Peter Lynch Fair Value 4.56
FSNUY's Price/Peter Lynch Fair Value is ranked lower than
87% of the 85 Companies
in the Global Medical Care industry.

( Industry Median: 2.47 vs. FSNUY: 4.56 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
FSNUY' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.66  Med: 1.19 Max: 4.58
Current: 4.56
0.66
4.58
Earnings Yield (Greenblatt) (%) 7.46
FSNUY's Earnings Yield (Greenblatt) (%) is ranked higher than
69% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 4.40 vs. FSNUY: 7.46 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
FSNUY' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 6.4  Med: 9.60 Max: 28.1
Current: 7.46
6.4
28.1
Forward Rate of Return (Yacktman) (%) 2.82
FSNUY's Forward Rate of Return (Yacktman) (%) is ranked lower than
70% of the 98 Companies
in the Global Medical Care industry.

( Industry Median: 10.04 vs. FSNUY: 2.82 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
FSNUY' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 0.5  Med: 12.60 Max: 31.4
Current: 2.82
0.5
31.4

More Statistics

Revenue(Mil) $28638
EPS $ 0.62
Beta0.44
Short Percentage of Float0.00%
52-Week Range $13.44 - 18.75
Shares Outstanding(Mil)2180.00

Analyst Estimate

Dec15 Dec16 Dec17
Revenue(Mil) 30,290 32,495 34,754
EPS($) 0.72 0.81 0.92
EPS without NRI($) 0.72 0.81 0.92

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, BDUUF, SKHCY » details
Traded in other countries:FREN.Germany, FRE.Switzerland, 0OO9.UK,
Fresenius SE & Co KGaA is a health care company. It offers products and services for dialysis, hospitals, and outpatient medical care. It also manage projects and provide services for hospitals and other health care facilities. The Company's business segments are: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. Fresenius Medical Care offers products and services for patients with chronic kidney failure. Fresenius Kabi specializes in infusion therapies, intravenously administered drugs (IV drugs), and clinical nutrition. The company is also a supplier of medical devices and products in the area of transfusion technology. Fresenius Helios operated a total of 74 hospitals with more than 23,000 beds in Germany. Fresenius Vamed manages projects and provides services for hospitals and other health care facilities. The Company operates in about 80 countries through its subsidiaries.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK